Shares of Akamai surge after deal with Anthropic. What Wall Street is saying
Source: CNBC

Akamai signed a 7-year, $11.6 billion cloud-computing contract with Anthropic, expandable to $20 billion, driving its shares up as much as 16.4% before gains moderated to roughly 8%. The agreement requires about $5.5 billion of Akamai capex and could add $150 million-$300 million of revenue in 2027, with Morgan Stanley estimating growth could accelerate to about 16% from 5% in 2025. Analysts view the deal as validating Akamai's AI cloud-infrastructure strategy, with $14.6 billion of cloud commitments signed year-to-date and estimated EBIT margins of roughly 30% at full run-rate.
Analysis
The key equity question is not the nominal contract value but whether Akamai can finance and commission capacity without diluting its legacy cash-generation profile. The required build creates a multi-year FCF trough before meaningful revenue recognition; if capacity is debt-funded, higher leverage and interest expense could absorb much of the initially projected operating-margin uplift. Investors should demand disclosure on take-or-pay terms, customer prepayments, deployment milestones, and the portion of capex that remains reusable if Anthropic demand changes.
Customer concentration is the underappreciated risk. A frontier-model customer can rapidly alter its inference architecture, migrate workloads, or negotiate pricing once dedicated capacity is installed; a seven-year headline commitment is materially less valuable if minimum-volume protections are weak. Conversely, successful deployment would validate Akamai's edge footprint as a differentiated low-latency inference platform, pressuring smaller edge/CDN peers such as FSLY and potentially creating demand for CPU servers, memory and network gear from suppliers including AMD, INTC, MU, DELL and ANET.
The initial share-price reaction likely discounts booking validation but not the 2027-28 execution valley. Consensus upgrades should continue over the next 1-3 months as analysts model the run-rate, but the more important 6-18 month catalyst is evidence that commissioned capacity, not signed commitments, is converting into revenue while consolidated FCF and leverage remain controlled. The contrarian view is that a CPU-centric deployment may prove economically attractive for agentic inference, but it also has lower switching costs and less hardware scarcity than GPU capacity, limiting durable pricing power.
A reversal would come from capex exceeding the indicated envelope, a material reduction in corporate buybacks, debt-funded expansion that pushes leverage above management's historical comfort range, delayed capacity turn-up, or any indication that customer commitments are cancellable or back-end loaded. The memory pre-buy is also a watch item: it reduces near-term component availability risk, but exposes Akamai to inventory and pricing risk if deployment timing slips.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.78
Ticker Sentiment
Key Decisions for Investors
- Do not chase AKAM immediately after the gap; initiate a 6-12 month long only on a pullback toward pre-announcement levels or after management provides binding minimum-commitment and financing detail. Upside comes from repeated revenue-estimate revisions; exit or hedge if 2027 cloud revenue guidance fails to move materially higher at the next earnings update.
- Express the competitive read-through as long AKAM / short FSLY over 3-6 months, sized modestly. Akamai's dedicated-compute wins strengthen its enterprise edge platform while FSLY lacks comparable balance-sheet capacity; cover the short if FSLY announces a similarly scaled contracted AI deployment or AKAM reveals uneconomic capex funding.
- Monitor MU and ANET for supplier confirmation rather than buy solely on the announcement. A long basket is warranted only if procurement disclosures show incremental external spending rather than internally absorbed inventory; memory pricing weakness or a delayed deployment schedule would invalidate the near-term read-through.
- Set an event-driven risk alert around the next earnings call: reduce AKAM exposure if management cannot reconcile capex, customer prepayments, and expected FCF. The critical metric is deployed-and-billed capacity versus contracted capacity, not additional headline bookings.
More News
- Beware borrowing costs: The jump in yields could hit these debt-laden stocks the most
- Akamai stock is surging. A $12 billion Anthropic deal reveals its powerful edge over cloud providers.
- Costco just reported strong earnings. Goldman Sachs sees a sharp move higher for the stock
- Surging Treasury yields are posing a brand new problem for Kevin Warsh and the Fed
- Akamai Stock Soars on $11.6 Billion Deal With Anthropic
- Akamai stock surges 23% on $12B Anthropic AI cloud deal: why it could double